Global ATP Assay Market Dynamics
Driver: Increasing food safety concerns
To ensure best-quality products with minimum health risks, several governments and companies have promulgated regulations to stipulate tolerable levels of contaminants, residues, and additives in food products. It reduces the risk of foodborne illnesses, closures, and recalls and can also improve efficiency and reduce costs
Food contamination is one of the major global concerns, which results in deaths, several health complications, and diseases.
Food production facilities rely on ATP tests to see if the food-contact surfaces are cleaned properly. It also checks that the surfaces are free from unsafe microbial loads and should adhere to the safety and quality of the products.
According to the Food Safety and Standards Authority of India, there is a consistent increase in food adulteration cases in India. Therefore, increasing food-safety concerns and the need to prevent adulteration and maintain the quality of food has increased the demand for ATP.
Expected Revenue Gains in Near Future:
The global ATP assay market is projected to reach USD 412 million by 2027 from USD 276 million in 2022, at a CAGR of 8.4%.
Restraint: High cost of instruments
The use of advanced cell viability assays is largely dependent on the availability of instruments, such as flow cytometers, high-throughput screening devices, luminometers, spectrophotometers, and high-content screening systems. As these systems are equipped with advanced features and functionalities, they are priced at a premium.
The cost of research in cell biology is high because of the need to maintain high-quality standards (use of high-grade, expensive products). Furthermore, it becomes difficult for small hospitals, diagnostic laboratories, and research & academic laboratories to acquire these instruments owing to budget constraints. In addition, the maintenance costs and several other indirect expenses result in an overall increase in the total cost of ownership of these instruments. This is a major factor limiting the adoption of instruments utilized for ATP assays, especially in emerging markets.
Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=223438780
Opportunity: Technological enhancements in ATP assay probes
Characterizing and understanding ATP dynamics provides valuable mechanistic insights into processes that range from neurotransmission to the chemotaxis of immune cells. Therefore, there is a need for a methodology to interrogate both the temporal and spatial components of ATP dynamics from the subcellular to organismal levels in live specimens. In the last several decades, a number of molecular probes that are specific for ATP have been developed. These probes have been combined with imaging approaches, particularly optical microscopy, to enable the qualitative and quantitative detection of this critical molecule.
While a number of ATP imaging technologies currently exist, there are still gaps in the ability to fully probe ATP metabolism and signaling. 1st generation ATP test methods use basic principles and, as such, provide users with only a semiquantitative measurement of ATP content. Second-generation protocols and reagents are specifically designed to mitigate various types of interferences found in water applications, including suspended solids, dissolved solids, biocides, and organics.
Challenge: Survival of small players and new entrants
The survival of small players and new entrants in the ATP assays market is a significant challenge. Established players have a robust product portfolio and strong brand recognition. As a result, it is difficult for small players and new entrants to compete with established players. Also, it is difficult for small players to sustain their operations and compete with established players that have large R&D budgets.
End Users:
The pharmaceutical and biotechnology companies segment accounted for the largest share of the ATP Assays market, by end user in 2021
Based on end users, the ATP assay market is segmented into pharmaceutical & biotechnology companies, the food & beverage industry, hospitals & diagnostic laboratories, and academic & research institutes. The large share of pharmaceutical and biotechnology segment can be attributed to the presence of a large number of pharmaceutical players with growing investments in this market, growing regulatory approvals for cell culture-based vaccines which require the use of ATP assays in contamination testing, commercial expansion of various pharmaceutical companies, the increasing demand for cell and gene therapies for chronic diseases, significant R&D in pharmaceutical & biopharmaceutical companies, increasing production of COVID-19 drugs, increasing adoption of cell-based assays for drug development, and the ease of use of ATP assay in contamination testing.
Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=223438780
Geographical Growth Dynamics:
North America accounted for the largest share of the ATP Assays market in 2021
In 2021, North America accounted for the largest share the ATP assay market, followed by Europe, Asia Pacific, Latin America, and the Middle East & Africa. The large share of North America can be attributed to the large pharmaceutical & biotechnology industry in the region, rising demand for cell-based assays in research, growing food safety concerns, and an increase in government funding for life science research.
